Ixekizumab Four-Week Dosing is Comparable to Two-Week Dosing in Psoriasis Patients and Reduces Treatment Costs: Experience in a Real-World Setting over a 12-Week Period
European Journal of Dermatology（2022）
Key words
psoriasis,biologic,Ixekizumab,real-world,efficacy,safety,dosing
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined